Isabel Denis
Family · Tavares, FLNPI 1568905537
Payments from drug & device makers
Across 221 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$304
- Pfizer$191
- Biohaven Pharmaceutical Holding Company Ltd.$142
- GSK$137
- Merck$133
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,681100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 87 | $1,109 |
| Novo Nordisk | 16 | $304 |
| Pfizer | 8 | $191 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $142 |
| GSK | 8 | $137 |
| Merck | 7 | $133 |
| Amgen | 7 | $123 |
| Johnson & Johnson | 3 | $119 |
| Amarin Pharma, Inc. | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Daiichi Sankyo Inc. | 6 | $104 |
| Abbott | 6 | $97 |
| AstraZeneca | 6 | $93 |
| Lilly USA, LLC | 5 | $88 |
| Astellas Pharma US Inc | 3 | $81 |
| Biohaven Pharmaceuticals, Inc. | 5 | $81 |
| Medtronic | 2 | $72 |
| Boston Scientific | 3 | $61 |
| Currax Pharmaceuticals LLC | 4 | $58 |
| Philips North America LLC | 2 | $54 |
| Exact Sciences | 3 | $50 |
| Boehringer Ingelheim | 2 | $37 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| Bausch Health US, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Halozyme Inc | 1 | $22 |
| Shield Therapeutics Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Genentech USA, Inc. | 2 | $16 |
| Coastal Medical Technologies LLC | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVNAR - 13$107
- TRUMENBA$107
- PREVNAR 20$107
How this compares
$3,681 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 17 | $22,696 |
| MounjaroTirzepatide | 18 | $21,947 |
| OzempicSemaglutide | 16 | $14,776 |
| Methylprednisolone | 103 | $1,072 |
| Estradiol | 12 | $961 |
| Famotidine | 40 | $776 |
| Atorvastatin Calcium | 68 | $772 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 64 | $726 |
| Levothyroxine Sodium | 61 | $700 |
| Losartan Potassium | 67 | $583 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $538 |
| Rosuvastatin Calcium | 40 | $517 |
| Metformin Hcl | 41 | $422 |
| Pantoprazole Sodium | 31 | $384 |
| Omeprazole | 27 | $371 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $133 | $22,69617 claims |
| Lilly USA, LLCMounjaro | $88 | $21,94718 claims |
| Novo NordiskOzempic | $304 | $14,77616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Tavares
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.